Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges
Open accessThe DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
Abstract
Unhealthy behaviours, including diet and physical activity, coupled with genetic predisposition, drive type 2 diabetes (T2D) occurrence and severity; the present review aims to summarise the most recent nutritional approaches in T2D, outlining unmet needs. Guidelines consistently suggest reducing energy intake to counteract the obesity epidemic, frequently resulting in sarcopenic obesity, a condition associated with poorer metabolic control and cardiovascular disease. Various dietary approaches have been proposed with largely similar results, with a preference for the Mediterranean diet and the best practice being the diet that patients feel confident of maintaining in the long term based on individual preferences. Patient adherence is indeed the pivotal factor for weight loss and long-term maintenance, requiring intensive lifestyle intervention. The consumption of nutritional supplements continues to increase even if international societies do not support their systematic use. Inositols and vitamin D supplementation, as well as micronutrients (zinc, chromium, magnesium) and pre/probiotics, result in modest improvement in insulin sensitivity, but their use is not systematically suggested. To reach the desired goals, patients should be actively involved in the collaborative development of a personalised meal plan associated with habitual physical activity, aiming at normal body weight and metabolic control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence from animal models shows that zinc supplementation reduces weight gain, abdominal fat accumulation, hyperinsulinemia, and leptin levels, while improving insulin resistance in obese mice fed a high-fat, high-fructose diet [183].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [183]
In the citing paper
“Evidence from animal models shows that zinc supplementation reduces weight gain, abdominal fat accumulation, hyperinsulinemia, and leptin levels, while improving insulin resistance in obese mice fed a high-fat, high-fructose diet [183].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [183]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“Intensive lifestyle intervention (ILI) that supports behaviour changes, as initially experienced in the Finnish Diabetes Prevention Study and the U.S. Diabetes Prevention Program [51,52], represents the recommended approach to prevent and/or delay the onset of T2D in prediabetic patients [5].”
BackgroundSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
Younossi, Z. M., Golabi, P., de Avila, L., Paik, J. M., Srishord, M., Fukui, N., Qiu, Y., Burns, L., Afendy, A., & Nader, F. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.021 · Cited by 2,235 · cited 1×
“Their accumulation due to higher synthesis and decreased export in the presence of high insulin concentrations in the portal vein is the likely cause of fatty liver disease, occurring in up to 73% of patients with T2D [33].”
BackgroundLean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095 · cited 1×
“At 12 months, almost half of participants achieved T2D remission off all glucose-lowering medications [57]; this percentage dropped to 36% at 24 months [58].”
BackgroundCruz-Jentoft, A. J., Landi, F., Schneider, S. M., Zuniga, C., Arai, H., Boirie, Y., Chen, L.-K., Fielding, R. A., Martin, F. C., Michel, J.-P., et al. (2014) · Age and Ageing · doi:10.1093/ageing/afu115 · Cited by 1,963
The Diabetes Prevention Program (DPP)
The Diabetes Prevention Program (DPP) Research Group (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2165 · Cited by 1,938
(2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.12.005 · Cited by 1,788
Effects of extended-release niacin with laropiprant in high-risk patients
The HPS2-THRIVE Collaborative Group (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1300955 · Cited by 1,668 · cited 1×
“Similar re-sults were provided by the large trial of combination treatment with niacin plus laropiprant [111], where niacin treatment (2 g/day for a median of 3.9 years) was associated with an increased incidence of de novo T2D (rate ratio, 1.32; 95% CI 1.16–1.51) and deterioration in metabolic…”
ResultInfluential
Research works printed but not linked: 1
- 14. Zimmet, P. The Negev desert, migration, islands and diabesity: Genes and environment clashing. In Proceedings of the Cohen Memorial Lecture 36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem, Israel, 17-21 September 2000.
Cited by
Items 101–130 of 130
Medications for the Management of Neuropathy
Brand-Eubanks, D. C. (2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch24
Mohamed, R. R., & Burbur, A. A. S. (2025) · Health Science Reports · doi:10.1002/hsr2.71591 · Cited by 1
Naseeb, M., Albajri, E. A., Hakim, N. A. N., Almasaudi, A. S., Afeef, S., Basaqr, R., Naghi, S. N., & Mosli, H. H. (2025) · International Journal for Vitamin and Nutrition Research · doi:10.31083/ijvnr45398
Sari, R. Y., Septianingrum, Y., Shodiq, M., Faizah, I., Rohmawati, R., & Hasina, S. N. (2025) · Jurnal PEPADU · doi:10.29303/pepadu.v6i3.8042
Morrissey, P. I., Clarke, E. D., Loh, X. T., Collins, C. E., Burrows, T. L., & Stanford, J. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70444 · Cited by 1
Petersen, E. E., Hansen, J. K., Torp, N., Gram-Kampmann, E.-M., Andersen, P., Johansen, S., Villesen, I. F., Bech, K., Thorhauge, K. H., Schnefeld, H. L., et al. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101211
Solís, E. C., Mendoza-Catalán, G. S., & Casas, C. Á. G. (2026) · doi:10.52501/cc.328.07
Exploring the Scope of Nutritional Counseling in Managing Diabetes: A Narrative Review
Kore, E., Shahu, S., Chandak, R. M., & Buty, A. (2026) · International journal of Nutrition Pharmacology Neurological Diseases · doi:10.4103/ijnpnd.ijnpnd_102_25
Frailty, sarcopenia, and diabetes: Managing physical decline
Hajam, Y. A., Bhatti, N., Kaur, A., Ahmed, S., & Rai, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44665-8.00005-5
Oktaviani, F., Purbaningsih, W., & Indrina, J. A. (2026) · Bandung Conference Series Medical Science · doi:10.29313/bcsms.v6i1.22323
Ahmed, N., Prajapati, H., Chauhan, M. R., Raval, V. H., Sehrawat, N., & Singh, N. A. (2025) · De Gruyter eBooks · doi:10.1515/9783112205150-007
Future prospective and challenges in neurobiology of type 2 diabetes
Dubey, M., Ranjan, S., & Kumar, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-32848-0.00016-9
Wang, J., Chen, Z., & Wang, M. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121637 · Cited by 1
Groves, E. A., Erol, Z., Baez-Lugo, S., Henchoz, N., & Motta, M. (2025) · International Association of Societies of Design Research Congress (IASDR) · doi:10.21606/iasdr.2025.178 · Cited by 1
Aralıklı oruç ile tip 2 diyabet ilişkisi: geleneksel derleme
Karadoğan, S. R., & Canbolat, E. (2026) · Sağlık akademisyenleri dergisi/Sağlık akademisyenler dergisi · doi:10.52880/sagakaderg.1690303
Sastre, L. R., Stroud, B. J., Schroeder, A., & Das, B. M. (2026) · American Journal of Lifestyle Medicine · doi:10.1177/15598276261442433 · Cited by 1
Psychological, Social, and Behavioral Aspects of Type 2 Diabetes: A Narrative Review
Sarvani, D. G. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.15s.45
Hábitos alimentarios y diabetes mellitus tipo 2 en adolescentes: revisión narrativa crítica
Izquierdo, A. C. E., & Chávez, J. G. P. (2026) · QhaliKay Revista de Ciencias de la Salud · doi:10.33936/qkrcs.v10i1.7815
Pinto, A., Conceição, G., Moreira, E., Santos, P. J., & Freitas, A. (2026) · Digital Health · doi:10.1177/20552076261435084
Fąfara, M., Jeczkało, M., Kosiorowska, M., Kowalczyk, A., Lasoń, J., Makulska, M., Płachta, W., Sęk, W., Sieradzka, A., & Wegenko, C. M. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5796
Genetic and epigenetic landscape of type 2 diabetes mellitus
Patil, P. C., Surve, S., Kaleem, M., Kayali, A., & Bachhav, R. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33590-7.00012-5
Ndlovu, N. (2026) · Journal of Herbmed Pharmacology · doi:10.34172/jhp.53271
Nutritional intake characteristics and glycemic control in patients with type 2 diabetes mellitus
Tang, Y.-B., Du, J., Zhou, H.-P., Guo, Y.-M., Shen, L.-S., Jiang, X., & Huang, S. (2026) · World Journal of Diabetes · doi:10.4239/wjd.122163
Chong, P. L., Yong, A. M. L., Musa, S., Mulok, M. A., Salleh, N. M., Azmi, I., Tey, J., Lee, Y., Jaafar, W., & Yung, C. K. (2026) · doi:10.2196/preprints.108620
Goode, R. W., Godoy, S. M., Harper-Cooks, T., Wolfe, H., Olson, K., Alexander, R., Campos, A. P., Robles, J., Aries, X. M., & Gary‐Webb, T. L. (2026) · Diabetes Obesity and Cardiometabolic CARE · doi:10.2337/doc26-0080
Li, Q., Chen, Y., Ye, W., Chen, L., Wu, K., Pan, D., Xia, H., Yang, L., Wang, S., Sun, G., et al. (2026) · International Journal for Vitamin and Nutrition Research · doi:10.31083/ijvnr50268
Šubová, L., Lenártová, P., Habánová, M., & Gažarová, M. (2026) · Roczniki Państwowego Zakładu Higieny · doi:10.32394/rpzh/235962
Huang, X., Duan, J., Liang, X., Li, Y., & Zhao, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1923121
Konstantopoulou, S. M., Foscolou, A., Papazafiropoulou, A. K., Makris, A. P., Leftaki, A. D., Panagiotopoulos, G., Gioxari, A., Lampropoulou, D. I., Detopoulou, P., Panoutsopoulos, G. I., et al. (2026) · Nutrients · doi:10.3390/nu18193130
Pérez, L. D. O., Sosa, K. E. C., Hernández, J. A. C., & Álvarez, H. R. P. (2026) · MULTIDISCIPLINARY HEALTH RESEARCH · doi:10.19136/mhr.a11n1.6701
Metadata
- Authors
- Petroni, M. L., Brodosi, L., Marchignoli, F., Sasdelli, A. S., Caraceni, P., Marchesini, G., & Ravaioli, F.
- Affiliations
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- University of Bologna (IT)
- Corresponding author
- Marchesini, Giulio
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2021-08-10
- Volume
- 13
- Issue
- 8
- Pages
- 2748
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC8401663
- OpenAlex
- W3187758220
- Cited by
- 116
- References
- 204
- Citations by year
- 2026: 21 · 2025: 33 · 2024: 31 · 2023: 22 · 2022: 8 · 2021: 1
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, nutrition, dietary intervention, Mediterranean diet, caloric restriction, sarcopenic obesity, weight loss, dietary adherence, lifestyle intervention, dietary supplements, myo-inositol, vitamin D, micronutrients, probiotics, prebiotics, insulin sensitivity, physical activity, obesity
- MeSH terms
- Diabetes Mellitus, Type 2, Diet, Diabetic, Humans, Patient Compliance, Exercise, Dietary Supplements, Caloric Restriction, Diet, Mediterranean, Nutrition Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.